Field Study to evaluate the activity of a site specific

Project: Research project

Description

Field Study to evaluate the activity of a site specific B-Domain Deleted (BDD) pegylated recombinant FVIII protein (BAY 94-9027) in plasma samples measured with both chromogenic and one stage assays used in clinical laboratories
StatusFinished
Effective start/end date10/20/156/30/16

Funding

  • BAYER HEALTHCARE LLC

Fingerprint

Recombinant Proteins
BAY 94-9027